Cytogenetics of pediatric acute myeloid leukemia

European Journal of Haematology

Volumn 83, Issue 5, 2009, Pages 391-405

  Manola, Kalliopi N ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Acute myeloid leukemia; Cytogenetic; Pediatric; Prognosis

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BIOLOGICAL MARKER; CLADRIBINE; CYTARABINE; ETOPOSIDE; MIXED LINEAGE LEUKEMIA PROTEIN; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEOPORIN 98; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; AGE DISTRIBUTION; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SURVIVAL; CHILDHOOD CANCER; CHROMOSOME 16Q; CHROMOSOME 7Q; CHROMOSOME 9Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DELETION 5; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DOWN SYNDROME; EVENT FREE SURVIVAL; FAMILIAL CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC EPIDEMIOLOGY; HUMAN; KARYOTYPE; MONOSOMY 7; OVERALL SURVIVAL; PATHOGENESIS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL RATE; TRISOMY 21; TRISOMY 8;

CARCINOGENS, ENVIRONMENTAL; CHROMOSOME ABERRATIONS; CYTOGENETICS; HUMANS; LEUKEMIA, MYELOID, ACUTE; PHARMACEUTICAL PREPARATIONS;

EID: 70349939681     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01308.x     Document Type: Review

References (123)

1. Hall GW. Childhood myeloid leukemias. Best Pract Res Clin Haematol 2001 14 : 573 591.
2. Creutzig U, Zimmermann M, Ritter J, et al. Treatment strategy and long term results in pediatric patients treated in four consecutive AML-BFM trials. Leukemia 2005 19 : 2030 2042.
3. Entz-Werle N, Suciu S, van der Werff ten Bosch J, et al. Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report. Leukemia 2005 19 : 2072 2081.
4. Gibson BE, Wheatley K, Hann IM, Stevens RF, Webb D, Hills RK, De Graaf SS, Harrison CJ. Treatment strategy and long term results in pediatric patients treated in consecutive UK AML trials. Leukemia 2005 19 : 2130 2138.
5. Perel Y, Auvrignon A, Leblanc T, et al. Treatment of childhood acute myeloblasic leukaemia: dose intensification improves outcome and maintenance therapy is of no benefit - multicenter studies of the French LAME Cooperative Group. Leukemia 2005 19 : 2082 2089.
6. Smith FO, Alonzo TA, Gerbing RB, Woods WG, Arceci RJ, for the Children's Cancer Group. Long-term result of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891. Leukemia 2005 19 : 2054 2062.
7. Meshinchi S, Arceci RJ. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia. The Oncologist 2007 12 : 341 355.
8. Lange BJ, Smith FO, Feusner J, et al. Outcomes in CCG-2961, a Children's Oncology Group Phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Blood 2008 111 : 1044 1053.
9. Kaspers GJL, Zwaan CM. Pediatric acute myeloid leukemia: towards high-quality cure of all patients. Haematologica 2007 92 : 1519 1532.
10. Rubnitz JE, Lensing S, Zhou Y, Sandlund JT, Razzouk BI, Ribeiro RC, Pui CH. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer 2004 101 : 1677 1684.
11. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004 22 : 4384 4393.
12. Slats AM, Egeler RM, van der Does-van den Berg A, Korbijn C, Hählen K, Kamps WA, Veerman AJ, Zwaam CM. Causes of death-other than progressive leukemia-in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia 2005 19 : 537 544.
13. Meshinchi S, Smith FO, Arceci RJ. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia. Curr Oncol Rep 2003 5 : 489 497. (Pubitemid 38906618)
14. Martinez-Climent JA. Molecular cytogenetics of childhood hematological malignancies. Leukemia 1997 11 : 1999 2021.
15. Leblanc T, Berger R. Molecular cytogenetics of childhood acute myelogenous leukemias. Eur J Haematol 1997 59 : 1 13.
16. Raimondi SC, Chang MN, Ravindranath Y, et al. Chromosomal abnormalities in 478 children with acute myeloid leukaemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood 1999 94 : 3707 3716.
17. Wells RJ, Arthur DC, Srivastava A, et al. Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 2002 16 : 601 607.
18. Ravindranath Y, Chang M, Steuber CP, et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005 19 : 2101 2116.
19. Betts DR, Ammann RA, Hirt A, Hengartner H, Beck-Popovic M, Kuhne T, Nobile L, Caflisch U, Wacker P, Niggli FK. The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG). European J Haematology 2007 78 : 468 476.
20. Forestier E, Heim S, Blennow E, et al. Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001. Br J Haematol 2003 121 : 566 577.
21. Webb DK, Harrison G, Stevens RF, Gibson BG, Hann IM, Wheatley K, MRC Childhood Leukemia Working Party. Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia. Blood 2001 98 : 1714 1720.
22. Alvarez S, Cigudosa JC. Gains, losses and complex karyotypes in myeloid disorders: a light at the end of the tunnel. Hematol Oncol 2005 23 : 18 25.
23. Creutzig U, Zimmermann M, Ritter J, et al. Definition of a standard-risk group in children with AML. Br J Haematol 1999 104 : 630 639.
24. Flandrin G. Classification of acute myeloid leukemias. Atlas Genet Cytogenet Oncol Haematol May 2002. URL: http://AtlasGeneticsOncology.org/ Anomalies/ClassifAMLID1238.html.
25. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009 0 : blood-2009-03-209262v1.
26. Mrózek K. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype. Semin Oncol 2008 35 : 365 377.
27. Kearney L, Horsley SW. Molecular cytogenetics in haematological malignancy: current technology and future prospects. Chromosoma 2005 114 : 286 294.
28. Fröhling S, Kayser S, Mayer C, Miller S, Wieland C, Skelin S, Schlenk RF, Döhner H, Döhner K, AML Study Group Ulm. Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemia. Haematologica 2005 90 : 194 199.
29. Lichter P, Joos S, Bentz M, Lampel S. Comparative genomic hybridization: uses and limitations. Semin Hematol 2000 37 : 348 357. (Pubitemid 30796694)
30. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998 92 : 2322 2333.
31. Stark B, Jeison M, Glazer Gabay L, et al. Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukemia: report from a referral centre in Israel. Br J Haematol 2004 126 : 320 337.
32. Zwaan CM, Meshinchi S, Radich JP, et al. FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. Blood 2003 102 : 2387 2394.
33. Goemans BF, Zwaan ChM, Miller M, et al. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Leukemia 2005 19 : 1536 1542.
34. Brown P, Mclntyre E, Rau R, Meshinchi S, Lacayo N, Dahl G, Alonzo TA, Chang M, Arceci RJ, Small D. The incidence and clinical significance of nucleophosmin mutations in childhood AML. Blood 2007 110 : 979 985.
35. Shimada A, Taki T, Tabuchi K, Taketani T, Hanada R, Tawa A, Tsuchida M, Horibe K, Tsukimoto I, Hayashi Y. Tandem duplications of MLL and FLT3 are correlated with poor prognosis in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group. Pediatr Blood Cancer 2008 50 : 264 269.
36. Basecke J, Whelan JT, Griesinger F, Bertrand FE. The MLL partial duplication in acute myeloid leukemia. Br J Haematol 2006 135 : 438 449.
37. Shimada A, Taki T, Kubota C, Tawa A, Horibe K, Tsuchida M, Hanada R, Tsukimoto I, Hayashi Y. No nucleophosmin mutations in pediatric acute myeloid leukemia with normal karyotype: a study of the Japanese Childhood AML Cooperative Study Group. Leukemia 2007 21 : 1307. (Pubitemid 46831822)
38. Bernstein J, Dastugue N, Haas OA, et al. Nineteen cases of the t(1;22)(p13;q13) acute megakaryoblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group. Leukemia 2000 14 : 216 218.
39. Martinez-Climent JA, Lane NJ, Rubin CM, et al. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 1995 9 : 95 101.
40. Dastugue N, Lafage-Pochitaloff M, Pagès M-P, et al. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Group Français de Cytogénétique Hématologique (GFCH). Blood 2002 100 : 618 626.
41. Arana Trejo RM, Aguilera RP, Nieto S, Kofman S. A t(1;22)(p13;q13) in four children with acute megakaryoblastic leukemia (M7), two with Down syndrome. Cancer Genet Cytogenet 2000 120 : 160 162.
42. Forestier E, Izraeli S, Beverloo B, Haas O, Pession A, Michalová K, Stark B, Harrison CJ, Teigler-Schlegel A, Johansson B. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an IBFM-SG study. Blood 2008 111 : 1575 1583.
43. Paredes-Aguilera R, Romero-Guzman L, Lopez-Santiago N, Arana Trejo R. Biology, clinical and hematologic features of acute megakaryoblastic leukemia in children. American J Hematol 2003 73 : 71 80.
44. Chessells JM, Harrison CJ, Kempski H, Webb DKH, Wheatley K, Hann IM, Stevens RF, Harrison G, Gibson BE. Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party. Leukemia 2002 16 : 776 784.
45. Mercher T, Busson-Le Coniat M, Monni R, et al. Involvement of a human gene related to the Drosophilia spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc Natl Acad Sci USA 2001 98 : 5776 5779.
46. Ma Z, Morris SW, Valentine V, Li M, et al. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13q13) of acute megakaryoblastic leukemia. Nat Genet 2001 28 : 220 221.
47. Ballerini P, Blaise A, Mercher T, et al. A novel real-time RT-PCR assay for quantification of OTT-MAL fusion transcript reliable for diagnosis of t(1;22) and minimal residual disease (MRD) detection. Leukemia 2003 17 : 1193 1196.
48. Haltrich I, Kost-Alimova M, Kovács G, Klein G, Fekete G, Imreh S. Multipoint interphase FISH analysis of chromosome 3 abnormalities in 28 childhood AML patients. Eur J Haematol 2006 76 : 124 133.
49. Athale UH, Razzouk BI, Raimondi SC, et al. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood 2001 97 : 3727 3732.
50. Tonnies H, Huber S, Kuhl JS, Gerlach A, Ebell W, Neitzel H. Clonal chromosome aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor. Blood 2003 101 : 3872 3874.
51. Meyer S, Fergusson WD, Whetton AD, et al. Amplification and translocation of 3q26 with over expression of EVII in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCDI/BRCA2 disruption. Genes Chromosomes Cancer 2007 46 : 359 372.
52. Jaju RJ, Haas OA, Neat M, et al. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG). Blood 1999 94 : 773 780.
53. Brown J, Jawad M, Twigg SRF, Saracoglu K, Sauerbrey A, Thomas AE, Eils R, Harbott J, Kearney L. A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay. Blood 2002 99 : 2526 2531.
54. Panarello C, Rosanda C, Morerio C. Cryptic translocation t(5;11)(q35;p15.5) with involvement of the NSD1 and NUP98 genes without 5q deletion in childhood acute myeloid leukemia. Genes Chromosomes Cancer 2002 35 : 277 281.
55. Mrózek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev 2004 18 : 115 136.
56. Chi Y, Lindgren V, Quigley S, Gaitonde S. Acute myelogenous leukemia with t(6;9)(p23;q34) and marrow basophilia. Arch Pathol Lab Med 2008 132 : 1835 1837.
57. von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A, Grosveld G. The translocation t(6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, DEK and CAN, and the expression of a chimeric, leukemia-specific DEK-CAN mRNA. Mol Cell Biol 1992 12 : 1687 1697.
58. Tosi S, Ballabio E, Teigler-Schlegel A, Boultwood J, Bruch J, Harbott J. Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia. Genes Chromosomes Cancer 2005 44 : 225 232.
59. Bresters D, Reus AC, Veerman AJ, van Wering ER, van der Does-van den Berg A, Kaspers GJ. Congenital leukaemia: the Dutch experience and review of the literature. Br J Haematol 2002 117 : 513 524.
60. Ferguson EC, Talley P, Vora A. Translocation (6;17)(q23;q11.2): a novel cytogenetic abnormality in congenital acute myeloid leukemia? Cancer Genet Cytogenet 2005 163 : 71 3.
61. Hasle H, Alonzo TA, Auvrignon A, et al. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood 2007 109 : 4641 4647.
62. Velloso ERP, Michaux L, Ferrant A, et al. Deletions of the long arm of chromosome 7 in myeloid disorders: loss of band 7q32 implies worst prognosis. Br J Haematol 1996 92 : 574 581.
63. Owen C, Barnett M, Fitzgibbon J. Familial myelodysplasia and acute myeloid leukemia - a review. Br J Haematol 2008 140 : 123 132. (Pubitemid 350265048)
64. Shannon KM, Turhan AG, Rogers PCJ, Kan YW. Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukaemia associated with monosomy 7. Genomics 1992 80 : 332 336.
65. Kwong YL, Ng MH, Ma SK. Familial acute myeloid leukemia with monosomy 7: late onset and involvement of a multipotential progenitor cell. Cancer Genet Cytogenet 2000 116 : 170 173.
66. Slater RM, von Drunen E, Kroes WG, et al. t(7;12)(q36;p13) and t(7;12)(q32;p13)-translocations involving ETV6 in children 18 months of age or younger with myeloid disorders. Leukemia 2001 15 : 915 920.
67. Beverloo HB, Panagopoulos I, Isaksson M, van Drunen E, de Klein A, Johansson B, Slater R. Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13). Cancer Res 2001 61 : 5374 5377.
68. von Bergh AR, van Drunen E, van Wering ER, van Zutven LJ, Hainmann I, Lönnerholm G, Meijerink JP, Pieters R, Beverloo HB. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9. Genes Chromosomes Cancer 2006 45 : 731 739.
69. Tosi S, Harbott J, Teigler-Schlegel A, et al. t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemia. Genes Chromosomes Cancer 2000 29 : 325 332.
70. Tosi S, Hughes J, Scherer SW, Nakabayashi K, Harbortt J, Haas OA, Cazzaniga G, Biondi A, Kempski H, Kearney L. Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia. Genes Chromosomes Cancer 2003 38 : 191 200.
71. Hama A, Yagasaki H, Takahashi Y, et al. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome. Br J Haematol 2008 140 : 552 561.
72. Abdelhaleem M, Shago M, Beimnet K, Sayeh E, Bartakke S, Weitzman S. Childhood acute myeloid leukaemia with hemophagocytosis by the blasts and inv(8)(p11q13) with MOZ-TIF2 fusion transcripts. J Pediatr Hematol Oncol 2007 29 : 643 645.
73. Murati A, Adelaide J, Popovici C, et al. A further case of acute myeloid leukemia with inv(8) chromosomal rearrangement and MOZ-NCO-A2 gene fusion. Int J Mole Med 2003 12 : 423 428.
74. Mo J, Lampkin B, Perentesis J, Poole L, Bao L. Translocation (8;18;16)(p11;q21;p13). A new variant of t(8;16)(p11;p13) in acute monoblastic leukemia: case report and review of the literature. Cancer Genet Cytogenet 2006 165 : 75 8.
75. Hann IM, Webb DK, Gibson BE, Harrison CJ. MRC trials in childhood acute myeloid leukaemia. Ann Hematol 2004 1 : S108 12.
76. Schoch C, Haase D, Haferlach T, et al. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor. Leukemia 1996 10 : 1288 1295.
77. Shimada A, Taki T, Tabuchi K, Tawa A, Horibe K, Tsuchida M, Hanada R, Tsukimoto I, Hayashi Y. KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group. Blood 2006 107 : 1806 1809.
78. Rubnitz JE, Raimondi SC, Halbert AR, et al. Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experience. Leukemia 2002 16 : 2072 2077.
79. Sweetser DA, Peniket AJ, Haaland C, et al. Delineation of the minimal commonly deleted segment and identification of candidate tumor-supressor genes in del(9q) acute myeloid leukemia. Genes Chromosomes Cancer 2005 44 : 279 291.
80. Morerio C, Acquila M, Rapella A, Tassano E, Rosanda C, Panarello C. Inversion (11)(p15q22) with NUP98-DDX10 fusion gene in pediatric acute myeloid leukemia. Cancer Genet Cytogenetics 2006 171 : 122 125.
81. Forestier E, Schmiegelow K, Nordic Society of Paediatric Haematology and Oncology NOPHO. The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations. J Pediatr Hematol Oncol 2006 28 : 486 495.
82. Rubnitz JE, Raimondi SC, Tong X, Srivastava DK, Razzouk BI, Shurtleff SA, Downing JR, Pui CH, Ribeiro RC, Behm FG. Favorable impact of the t(9;11) in childhood acute myeloid leukemia. J Clin Oncol 2002 20 : 2302 2309.
83. Chowdhury T, Brady HJ. Insights from clinical studies into the role of the MLL gene in infant and childhood leukaemia. Blood Cells Mol Dis 2008 40 : 192 199.
84. Vardiman JW, Harris NL, Brunning RD, The World Health Organization (WHO). Classification of the myeloid neoplasms. Blood 2002 100 : 2292 2302.
85. Pui CH, Raimondi SC, Srivastava DK, Tong X, Behm FG, Razzouk B, Rubnitz JE, Sandlund JT, Evans WE, Ribeiro R. Prognostic factors in infants with acute myeloid leukemia. Leukemia 2000 14 : 684 687.
86. Shih LY, Liang DC, Fu JF, et al. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia 2006 20 : 218 223.
87. Lie SO, Abrahamsson J, Clausen N, et al. Long-term results in children with AML: NOPHO-AML Study Group-report of three consecutive trials. Nordic Society of Pediatric Hematology and Oncology (NOPHO); AML Study Group. Leukemia 2005 19 : 2090 2100.
88. Swansbury GJ, Slater R, Bain BJ, Moorman AV, Secker-Walker LM. Hematological malignancies with t(9;11)(p21-22;q23) - a laboratory and clinical study of 125 cases. European 11q23 Workshop participants. Leukemia 1998 12 : 792 800.
89. Nigro L, Bottino D, Panarello C, Moreiro C, Mirabile E, Rapella AM, Cataldo A, Schiliro G. Prognostic impact of t(9;11) in childhood acute myeloid leukemia (AML). Leukemia 2003 17 : 636 656.
90. Martineau M, Berger R, Lillington DM, Moorman AV, Secker-Walker LM. The t(6;11)(q27;q23) translocation in acute leukemia: a laboratory and clinical study of 30 cases. EU concerted action 11q23 Workshop participants. Leukemia 1998 12 : 788 791.
91. Lillington DM, Young BD, Berger R, Martineau M, Moorman AV, Secker-Walker LM. European 11q23 Workshop participants. The t(10;11)(p12q23) translocation in acute leukemia: a cytogenetic and clinical study of 20 patients. Leukemia 1998 12 : 801 804.
92. Dreyling MH, Schrader K, Fonatsch C, et al. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukaemia with translocation t(10;11): both rearrangements are associated with a poor prognosis. Blood 1998 91 : 4662 4667.
93. Casillas JN, Woods WG, Hunger SP, McGavran L, Alonzo TA, Feig SA, Children's Cancer Group. Prognostic implications of t(10;11) translocations in childhood acute myelogenous leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol 2003 25 : 594 600.
94. Stasevich I, Utskevich R, Kustanovich A, Litvinko N, Savitskaya T, Chernyavskaya S, Saharova O, Aleinikova O. Translocation (10;11)(p12;q23) in childhood acute myeloid leukemia: incidence and complex mechanism. Cancer Genet Cytogenet 2006 169 : 114 120.
95. Moorman AV, Hagemeijer A, Charrin C, Rieder H, Secker-Walker LM. The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. European 11q23 Workshop participants. Leukemia 1998 12 : 805 810.
96. Mantadakis E, Samonis G, Kalmanti M. A comprehensive review of acute promyelocytic leukemia in children. Acta Haematol 2008 119 : 73 82.
97. Chan NPH, Wong WS, Ng MHL, Tsang KS, Lau TT, Leung Y, Chik KW, Shing MMK, Li CK. Childhood acute myeloid leukaemia with CBFβ-MYH11 rearrangement: study of incidence, morphology, cytogenetics, and clinical outcomes of Chinese in Hong Kong. Am J Hematology 2004 76 : 300 303.
98. Yang CP, Wu JH, Hung IJ, Jaing TH. Cytogenetic pattern of childhood leukemia in Taiwan. J Formos Med Assoc 2000 99 : 281 289.
99. Chang M, Raimondi SC, Ravingranath Y, et al. Prognostic factors in children and adolescents with acute myeloid leukaemia (excluding children with Down syndrome and acute promyelocytic leukaemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821. Leukemia 2000 14 : 1201 1207.
100. Arrigoni P, Beretta C, Silvestri D, Rossi V, Rizzari C, Valsecchi MG, Cazzaniga G, Biondi A. FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukemia. Br J Haematol 2003 120 : 89 92.
101. Xu W, Zhou HF, Fan L, Qian SX, Chen LJ, Qiu HR, Zhang SJ, Li JY. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16. Oncologie 2008 31 : 440 444.
102. Kong XT, Ida K, Ichikawa H, et al. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood 1997 90 : 1192 1199.
103. Imashuku S, Hibi S, Sako M, et al. Hemophagocytosis by leukemic blasts in 7 acute myeloid cases with t(16;21)(p11;q22): common morphologic characteristics for this type of leukemia. Cancer 2000 88 : 1970 1975.
104. Fleìshman EV, Sokova OI, Kirichenko OP, Konstantinova LN, Metel'kova NF, Popa AV, Shneìder MM. Complex karyotype abnormalities in pediatric acute myeloid leukemia. Vestn Ross Akad Med Nauk 2008 5 : 3 7.
105. Nakase K, Bradstock K, Sartor M, Gottlieb D, Byth K, Kita K, Shiku H, Kamada N the Japanese Cooperative Group of Leukemia/Lymphoma. Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases. Leukemia 2000 14 : 163 168.
106. Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukaemia of Down syndrome. Nat Genet 2002 32 : 148 152.
107. Hitzler JK, Zipursky A. Origins of leukemia in children with Down syndrome. Nat Rev Cancer 2005 5 : 11 20.
108. Rainis L, Bercovich D, Strehl S, et al. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 2003 102 : 981 986.
109. Tabori U, Revah G, Nathan PC, Strahm B, Rachlis A, Shago M, Grant R, Doyle J, Malkin D. Toxicity and outcome of children with treatment related acute myeloid leukemia. Pediatr Blood Cancer 2008 50 : 17 23.
110. Barnard DR, Woods WG. Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer-an update. Leuk Lymphoma 2005 46 : 651 663.
111. Creutzig U, Büchner T, Sauerland MC, Zimmermann M, Reinhardt D, Döhner H, Schlenk RF. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLHD93/98A. Cancer 2008 112 : 562 571.
112. Razzouk BI, Estey E, Pounds S, et al. Impact of age on outcome of pediatric acute myeloid leukemia. Cancer 2006 106 : 2495 2502.
113. Wiemels JL, Xiao Z, Buffler PA, et al. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 2002 99 : 3801 3805.
114. McHale CM, Wiemels JL, Zhang L, Ma X, Buffler PA, Feusner J, Matthay K, Dahl G, Smith MT. Prenatal origin of childhood acute myeloid leukaemia harboring chromosomal rearrangements t(15;17) and inv(16). Blood 2003 101 : 4640 4641.
115. Smith MT, McHale CM, Wiemels JL, Zhang L, Wiencke JK, Zheng S, Gunn L, Skibola CF, Ma X, Buffler PA. Molecular biomarkers for the study of childhood leukemia. Toxicol Appl Pharmacol 2005 206 : 237 245.
116. Mori H, Colman SM, Xiao Z, et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 2002 99 : 8242 8247.
117. LaFiura KM, Bielawski DM, Posecion NC Jr., Ostrea EM Jr., Matherly LH, Taub JW, Ge Y. Association between prenatal pesticide exposures and the generation of leukemia-associated t(8;21). Pediatr Blood Cancer 2007 49 : 624 628.
118. Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, Greaves MF. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 1997 94 : 13950 13954.
119. Ross JA. Dietary flavonoids and the MLL gene: a pathway to infant leukemia? Proc Natl Acad Sci USA 2000 97 : 4411 4413.
120. Spector LG, Xie Y, Robinson LL, et al. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the Children's Ongology Group. Cancer Epidemiol Biomark Prev 2005 14 : 651 655.
121. Alexander FE, Patheal SL, Biondi A, et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 2001 61 : 2542 2546.
122. Zwaan CM, Kaspers GJL, Pieters R, Hählen K, Huismans DR, Zimmermann M, Harbott J, Slater RM, Creutzig U, Veerman AJP. Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities. Blood 2002 100 : 3352 3360.
123. Styczyński J, Haus O. Cytogenetics and in vitro drug resistance of acute leukemia in children and adults. Postepy Hig Med Dosw (Online) 2006 60 : 527 537.